The Joint Blog

JANUARY 31, 2021

The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. Case presentation.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Cannabis Law Report

SEPTEMBER 22, 2021

New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced new data demonstrating Supera-CBD’s superior potency over CBD by factor of 8,000 times. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

OCTOBER 19, 2021

Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that it will present at the Dawson James Securities 6th Annual Small Cap Growth Conference on Thursday, October 21, 2021, at 4:30 p.m. ET in Track 1. MyMD Chief Scientific Officer Adam Kaplin, M.D.,

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 1, 2021

Format: Presentation and 1×1 meetings (virtual). Presentation time: Wednesday, December 8 at 4:00 p.m. The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. Date: December 2, 2021. Format: 1-on-1 meetings (virtual).

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

CannaTech

SEPTEMBER 16, 2018

These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Similar frameworks exist across the world, presenting the same set of challenges Canada has faced along the way. It’s simply a matter of getting this information into the hands of both patients and doctors.

Education 66

Education Medicine Clinical Trials Patients 66

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

Unlike some other cannabinoids, it is not present in substantial amounts in fresh cannabis flower. As mentioned, CBN is also not present in therapeutic amounts in most cannabis flower. CBN has the potential to treat many other conditions. A list of some of the conditions CBN has been studied about in treatment purposes follows.

Sleep 94

Sleep Cannabinoids THC CBD 94

The Joint Blog

JANUARY 23, 2020

. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. Yet its potential application in the field of psychiatry is lesser known.”

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Cannabis Law Report

OCTOBER 26, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, announced today that Chris Chapman, M.D., Dr. Chapman is a seasoned executive and global medical expert with extensive experience in designing and clinical trial protocols and conducting clinical trials.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Otherside Farms

APRIL 14, 2020

In another study, people dealing with epilepsy were given 200-300mg of CBD daily and began to experience fewer seizures. A good example is that of Charlotte Figi, a young girl who had Dravet’s Syndrome , which is a rare condition that is hard to treat using conventional medicines. Side Effects From Chemotherapy.

CBD 52

CBD Research and Development Sleep Clinical Trials 52

Cannabis Law Report

DECEMBER 7, 2021

This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. Therefore, a summary table of adverse mental events is presented with Conditional maximum likelihood estimate of Rate Ratio and Fischer exact test 46.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

SEPTEMBER 1, 2019

The Victorian and New South Wales Governments had both begun clinical trials of cannabis products for children with severe epilepsy and for palliative care, respectively. Fast forward to the present day. The clinical trials and the standard of production could lead the world.”.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

APRIL 10, 2019

In November, UK law changed to allow clinicians to prescribe medical cannabis under limited conditions. In relation to childhood epilepsy, the British Paediatric Neurology Association has issued interim clinical guidance. Here’s a quick precis care of Cannabis Wire Daily Newswire.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

DECEMBER 21, 2019

Autism is a very serious health condition that affects patients’ communication and social interaction skills thus making the development and maintenance of a social relationship very difficult. Unlike most conditions, not much is known about autism. A closer look at CBD And Autism.

Research and Development 59

Research and Development CBD Conditions Therapy 59

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Refractory paediatric epilepsy. Spasticity from neurological conditions.

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. It is the most commonly identified cause of epilepsy among adults. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Investor Presentation Information. Eleusis and Silver Spike have prepared a prerecorded investor presentation.

Therapy 52

Therapy Research and Development Business Access 52

SMPL

MAY 26, 2020

Within a couple of years, they figured out a 1:1 combination of a high-THC chemovar and a high-CBD chemovar presented the greatest latitude of effects and prevention of side effects,” said Dr. Ethan Russo, who worked with GW Pharmaceuticals from 1998 to 2014. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. It is the most commonly identified cause of epilepsy among adults. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

DECEMBER 30, 2019

State lawmakers passed Assembly Bill 420 , which authorizes the University of California’s Center for Medicinal Cannabis Research to cultivate cannabis for clinical trials. The measure adds anxiety, autism, opioid addiction or dependence, anorexia nervosa, among other qualifying conditions. California. New Hampshire.

Legislation 59

Legislation Patients Access Banking 59

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

AUGUST 12, 2019

Broad spectrum oil — An oil rich in CBD and the beneficial cannabinoids and terpenes present in hemp EXCEPT for THC. Federally Recognized Medical Conditions. Consult with a physician before use if you have a serious medical condition or use prescription medications. Frequently Asked Questions for Beginners.

CBD 40

CBD Terpenes Oil Tincture 40